Keyphrases
Maintenance Treatment
100%
Cost-effectiveness
100%
Schizophrenia Treatment
100%
Haloperidol Decanoate
100%
Long-acting Injectable
100%
Paliperidone Palmitate
100%
Quality-adjusted Life Years
62%
Long-acting Injectable Antipsychotics
37%
United States
12%
Clinical Research
12%
Clinical Trials
12%
Schizoaffective Disorder
12%
Schizophrenia
12%
Health Care Costs
12%
Health Systems
12%
Confidence Interval
12%
Negative Syndrome
12%
Intramuscular Injection
12%
High Cost
12%
Schizophrenia Symptoms
12%
Bootstrap Analysis
12%
Incremental Cost-effectiveness Ratio
12%
Mixed Model Analysis
12%
Inpatient Services
12%
Relative Cost
12%
Effect Assessment
12%
Outpatient Services
12%
Benefit Analysis
12%
Net Health Benefit
12%
Medicine and Dentistry
Maintenance Therapy
100%
Cost-Effectiveness Analysis
100%
Treatment of Schizophrenia
100%
Paliperidone
100%
Haloperidol Decanoate
100%
Quality Adjusted Life Year
62%
Health Care Cost
50%
Drug Therapy
25%
Clinical Research
12%
Clinical Trial
12%
Outpatient
12%
Mixed Model
12%
Cost Benefit Analysis
12%
Bootstrapping
12%
Intramuscular Injection
12%
Health System
12%
Schizoaffective Disorder
12%
Positive and Negative Syndrome Scale
12%
Side Effect Assessment
12%
Nursing and Health Professions
Maintenance Therapy
100%
Cost Effectiveness Analysis
100%
Haloperidol Decanoate
100%
Paliperidone
100%
Quality Adjusted Life Year
62%
Drug Therapy
25%
Health Care Cost
12%
Confidence Interval
12%
Bootstrapping
12%
Intramuscular Drug Administration
12%
Schizoaffective Psychosis
12%
Outpatient Care
12%
Positive and Negative Syndrome Scale
12%
Side Effect Assessment
12%
Incremental Cost-Effectiveness Ratio
12%
Neuroscience
Haloperidol
100%
Treatment of Schizophrenia
100%
Decanoic Acid
100%
Paliperidone
100%
Antipsychotic
37%
Dementia Praecox
25%
Schizoaffective Disorder
12%
Negative Syndrome
12%
Positive Syndrome
12%
Pharmacology, Toxicology and Pharmaceutical Science
Paliperidone
100%
Haloperidol Decanoate
100%
Antipsychotic
37%
Clinical Trial
12%
Clinical Research
12%
Side Effect
12%
Positive Syndrome
12%
Negative Syndrome
12%
Schizoaffective Psychosis
12%
Intramuscular Injection
12%
Mixed Model
12%